1,2 In recent years, the treatment landscape of ABC has evolved dramatically with the development of novel anti-cancer agents, such as CDK (cyclin-dependent kinase) 4/6 inhibitors and ADCs (antibody-drug conjugates). Based on the Guidelines for Clinical Diagnosis and Treatment of Advanced ...
early breast cancertherapy decisionsexpert panelThe continuous availability of findings from new studies repeatedly results in updated treatment recommendations and guidelines. In the case of breast carcinoma in particular, several studies have been published in the last few years that have transformed how...
through literature research and expert discussion and evaluated the relevant evidence with reference to the grading of recommendations assessment,development,and evaluation.The CSBrS formulated the clinical practice guidelines to provide a reference for physicians specializing in breast cancer and other fields...
The Japanese Breast Cancer Society (JBCS) Clinical Practice Guidelines for systemic treatment of breast cancer were updated to the 2022 edition through a p
According to the American Joint Committee on Cancer (AJCC) guidelines, Neo-Bioscore is calculated by considering for each patient the pretreatment clinical stage and the post-treatment pathologic stage.26 Additional points are added in case of ER-negative disease, nuclear grade 3 tumours, and HER2...
《Translational Breast Cancer Research》、《Gland Surgery》编委 第一/共同第一/通讯作者发表SCI论文40余篇(《Lancet Oncol》等) 参考文献 [1]H.S. Rugo, W. Jacot, E. Tokunaga, et al. Trastuzumab deruxtecan (T-DXd) vs treatment of physician’s choice (TPC) in patients (pts) with HER2-low...
Article Open access 05 July 2021 Introduction From 1995 on, many relevant advances in early breast cancer (BC) treatment have contributed to the improvement in patient survival. For instance, the emergence of anthracycline1 and taxane-based therapies2 and the identification of intrinsic subtypes3. ...
Clinical practice guidelines for sentinel lymph node biopsy in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021. Chin Med J 2021;134:886-894. doi: 10.1097/CM9.0000000000001410 . 返回引文位置Google Scholar 百度学术 万方数据 2. Tukenmez M...
[3] Howie LJ,Scher NS,Amiri-Kordestani L,et al.FDA approval summary: pertuzumab for adjuvant treatment of HER2-positive early breast cancer[J]. Clin Cancer Res, 2019,25(10):2949-2955. [4] Nami B, Maadi H, Wang Z. Mechanisms underlying the action and synergism of trastuzumab and pertu...
Evaluation of the ability of the Clinical Treatment Score at 5 years (CTS5) compared to other risk stratification methods to predict the response to an extended endocrine therapy in breast cancer patients Andrea Villasco Francesca Accomasso Nicoletta Biglia Breast Cancer (2021)Download...